(S (NP (PRP We)) (VP (VBP study) (NP (DT the) (NML (NML (NNP SIRS)) (-LRB- -LRB-) (NML (ADJP (JJ Susceptible) (HYPH -) (SBAR (S (NP (NP (NP (JJ Infected)) (HYPH -) (VP (VBN Recovered) (HYPH -) (S (ADJP (JJ Susceptible))))) (-RRB- -RRB-) (SBAR (S (VP (VBG spreading) (NP (NNS processes)) (PP (IN over) (NP (JJ complex) (NNS networks))) (, ,) (PP (IN by) (S (VP (VBG considering) (NP (NP (NP (PRP$ its) (JJ exact) (NML ($ $) (CD 3))) (SYM ^) (NP (NN n))) (NP (NML (NML ($ $)) (HYPH -) (NN state)) (NNP Markov))))))))))))) (NN chain))) (NN model))) (. .))
(S (NP (DT The) (NNP Markov) (NN chain) (NN model)) (VP (VBZ exhibits) (NP (NP (NP (DT an) (JJ interesting) (NN connection)) (PP (IN with) (NP (PRP$ its) (NML ($ $) (CD 2n)) (NML (NML ($ $)) (HYPH -) (NN state)) (JJ nonlinear) (NML (`` ") (S (VP (VB mean) (HYPH -) (NP (NN field)))) ('' ")) (NN approximation)))) (CC and) (NP (NP (DT the) (NN latter) (POS 's)) (VBG corresponding) (JJ linear) (NN approximation)))) (. .))
(S (PP (IN In) (NP (NN fact))) (, ,) (NP (DT the) (NN epidemic) (NN eradication) (NN condition)) (VP (VBZ coincides) (PP (IN for) (NP (PDT all) (DT the) (CD three) (NNS models)))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN threshold) (NN condition)) (VP (VBZ is) (VP (VBN violated))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ indicates) (SBAR (IN that) (S (NP (DT the) (JJ linear) (NN model)) (VP (VBZ is) (RB not) (ADJP (JJ stable)))))))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (EX there)) (VP (VBZ exists) (NP (NP (DT a) (JJ unique) (NML (JJ second) (VBN fixed)) (NN point)) (PP (IN for) (NP (NP (DT the) (JJ nonlinear) (NN model)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ corresponds) (PP (IN to) (NP (DT the) (JJ endemic) (NN state))))))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VB investigate) (NP (NP (DT the) (NN effect)) (PP (IN of) (S (VP (VBG adding) (NP (NN immunization)) (PP (IN to) (NP (DT the) (NNP SIRS) (NNS epidemics))) (PP (IN by) (S (VP (VBG introducing) (NP (CD two) (JJ different) (NNS models)) (, ,) (PP (VBG depending) (PP (IN on) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (DT the) (NN vaccine)))))))))))))) (. .))
(S (NP (PRP$ Our) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN immunization)) (VP (VBZ improves) (NP (NP (DT the) (NN threshold)) (PP (IN of) (NP (NN epidemic) (NN eradication)))))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP (NP (DT the) (JJ common) (NN threshold)) (PP (IN for) (NP (NP (NP (JJ fast) (HYPH -) (NN mixing)) (PP (IN of) (NP (DT the) (NNP Markov) (NN chain)))) (CC and) (NP (NP (JJ global) (NN stability)) (PP (IN of) (NP (ADJP (NP (DT the) (NN disease)) (HYPH -) (JJ free)) (NML (VBN fixed) (NN point)))))))) (VP (VBZ improves) (PP (IN by) (NP (NP (DT the) (JJ same) (NN factor)) (PP (IN for) (NP (DT the) (ADJP (NN vaccination) (HYPH -) (JJ dominant)) (NN model)))))) (. .))
